CS
BLFS icon

Cannell & Spears’s BioLife Solutions BLFS Stock Holding History

Cannell & Spears’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$502K Sell
17,778
-8,483
-32% -$198K 0.01% 314
2026
Q1 		$501K Buy
26,261
+825
+3% +$18.2K 0.01% 301
2025
Q4 		$615K Hold
25,436
– – 0.01% 273
2025
Q3 		$649K Sell
25,436
-159
-0.6% -$3.77K 0.01% 268
2025
Q2 		$551K Hold
25,595
– – 0.01% 279
2025
Q1 		$585K Sell
25,595
-400
-2% -$10.5K 0.01% 271
2024
Q4 		$675K Sell
25,995
-1,322
-5% -$32.9K 0.01% 266
2024
Q3 		$684K Hold
27,317
– – 0.01% 266
2024
Q2 		$585K Sell
27,317
-35
-0.1% -$679 0.01% 257
2024
Q1 		$507K Hold
27,352
– – 0.01% 281
2023
Q4 		$444K Hold
27,352
– – 0.04% 143
2023
Q3 		$378K Sell
27,352
-1,450
-5% -$22.8K 0.03% 149
2023
Q2 		$637K Sell
28,802
-280
-1% -$5.9K 0.05% 117
2023
Q1 		$633K Hold
29,082
– – 0.06% 120
2022
Q4 		$529K Hold
29,082
– – 0.05% 127
2022
Q3 		$662K Sell
29,082
-270
-0.9% -$5.78K 0.07% 104
2022
Q2 		$405K Buy
29,352
+6,000
+26% +$88K 0.04% 146
2022
Q1 		$531K Buy
23,352
+209
+0.9% +$5.5K 0.04% 143
2021
Q4 		$863K Buy
23,143
+614
+3% +$26.4K 0.06% 110
2021
Q3 		$953K Sell
22,529
-4,102
-15% -$198K 0.07% 99
2021
Q2 		$1.19M Sell
26,631
-560
-2% -$19.7K 0.09% 92
2021
Q1 		$979K Buy
27,191
+48
+0.2% +$1.9K 0.08% 92
2020
Q4 		$1.08M Buy
27,143
+1,071
+4% +$36.5K 0.09% 88
2020
Q3 		$755K Hold
26,072
– – 0.07% 98
2020
Q2 		$426K Buy
26,072
+210
+0.8% +$2.9K 0.04% 130
2020
Q1 		$246K Buy
25,862
+7,795
+43% +$107K 0.03% 170
2019
Q4 		$292K Buy
18,067
+4,467
+33% +$72.6K 0.03% 149
2019
Q3 		$226K Hold
13,600
– – 0.03% 161
2019
Q2 		$231K Hold
13,600
– – 0.03% 159
2019
Q1 		$243K Buy
+13,600
New +$216K 0.03% 151

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Cannell & Spears's BLFS Position: Q2 2026 in Review

Cannell & Spears reduced its BioLife Solutions (BLFS) stake by 32% in Q2 2026, selling an estimated $198K and leaving 17,778 shares worth $502K. The position accounts for 0.01% of the portfolio, ranked #314.

Cannell & Spears first reported a position in BLFS in Q1 2019 and has held it in 30 quarters since. The position peaked at $1.19M in Q2 2021. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Cannell & Spears held 17,778 shares of BioLife Solutions worth $502K as of Q2 2026.
  • Cannell & Spears sold 8,483 BioLife Solutions shares in Q2 2026, an estimated $198K.
  • BioLife Solutions made up 0.01% of Cannell & Spears's portfolio in Q2 2026, its #314 holding.
  • Cannell & Spears first reported a position in BioLife Solutions in Q1 2019 and has held it in 30 quarters since.
  • Cannell & Spears's BioLife Solutions position peaked at $1.19M in Q2 2021.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Cannell & Spears's 13F filing for Q2 2026, filed 11 Aug 2026.